Senti Biosciences, Inc. (SNTI)
Largest Insider Buys in Sector
SNTI Stock Price History Chart
SNTI Stock Performance
About Senti Biosciences, Inc.
Senti Biosciences, Inc. operates as a gene circuit company. The company develops cell and gene therapies engineered with gene circuits that are designed to reprogram cells with biological logic to sense inputs, compute decisions, and respond to respective cellular environments. Its synthetic biology platform utilizes off-the-shelf chimeric antigen receptor natural killer (CAR-NK) cells to target particularly challenging liquid and solid tumor oncology indications. The company's lead programs include SENTI-202, a Logic Gated OR+NOT off-the-shelf …
Insider Activity of Senti Biosciences, Inc.
Over the last 12 months, insiders at Senti Biosciences, Inc. have bought $0 and sold $0 worth of Senti Biosciences, Inc. stock.
On average, over the past 5 years, insiders at Senti Biosciences, Inc. have bought $0 and sold $0 worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 800 shares for transaction amount of $3,320 was made by Browne Leslie J (President and CEO) on 2013‑12‑19.
List of Insider Buy and Sell Transactions, Senti Biosciences, Inc.
| 2013-12-19 | President and CEO | 800 0.0335% | $4.15 | $3,320 | ||||
| 2013-05-20 | President and CEO | 30,000 0.0121% | $0.04 | $1,200 |